Aquestive Therapeutics, Inc. AQST Total debt

Total debt at other companies

Indivior Pharmaceuticals, Inc.INDV

$509M+37.6%

ARS Pharmaceuticals, Inc.SPRY

$96.52M+132,122%

ViatrisVTRS

$13.63B-7.7%

AMP

Amphastar PharmaceuticalsAMPH

$688.51M+5.0%

AbbVieABBV

$62.36B+1.8%

Avalo TherapeuticsAVTX

$242K-64.4%

FAQ

What is Aquestive Therapeutics, Inc.'s total debt?

Aquestive Therapeutics, Inc. (AQST) reported total debt of $64.36M in Q1 2026.

How has Aquestive Therapeutics, Inc.'s total debt changed year-over-year?

Aquestive Therapeutics, Inc.'s total debt increased by 7.4% year-over-year, from $59.9M to $64.36M.

What is the long-term trend for Aquestive Therapeutics, Inc.'s total debt?

Over 5 years (2020 to 2025), Aquestive Therapeutics, Inc.'s total debt has grown at a 75.6% compound annual growth rate (CAGR), from $3.57M to $59.62M.

What does total debt mean?

Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.